How does methyldopa therapy impact glucose metabolism in patients with metabolic syndrome and what are the implications for diabetes risk?
Lakshya KumarExplorer
How does methyldopa impact glucose metabolism in patients with metabolic syndrome?
Share
1. Methyldopa can impair glucose tolerance, potentially increasing diabetes risk in metabolic syndrome patients.
2. Methyldopa therapy may worsen insulin resistance, heightening diabetes risk among those with metabolic syndrome.
3. Methyldopa has been linked to altered glucose metabolism, which might escalate the risk of diabetes in patients with metabolic syndrome.